NASDAQ:CTOR | Cash Flow Statement | CITIUS ONCOLOGY, INC.

Complete source-backed cash-flow history.

Available history
2021-06-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$8.92M
2026-03-31-$26.61M
2025-12-31-$5.53M-$7.35M-$4.4M$15.13M
2025-09-30-$5M
2025-06-30-$5.37M
2025-03-31-$7.74M
2024-12-31-$6.66M
2024-09-30-$6.81M
2024-06-30-$4.77M
2024-03-31-$4.84M-$191,690.00$24.74M-$24.55M
2023-12-31-$4.73M-$218,777.00-$660,000.00$885,000.00
2023-09-30$157,943.00
2023-06-30$616,296.00
2023-03-31$611,725.00-$168,799.00
2021-06-30-$724.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-09-30-$24.76M-$5.49M-$5.75M$15.17M
2024-09-30-$21.15M$126,353.00-$5M$4.87M
2023-12-31$2.42M-$601,304.00-$1.32M$1.66M
2023-09-30-$12.7M
2022-12-31$380,811.00-$47,968.00-$67.32M$67.66M